Find Publications

Search in all content

Filters for Publications

Search concepts
Selected Filters

Publication Year

  • 2020
  • 2019
  • 2017
  • 2016

Author

  • Liang Cheng
2017

Complexity of the genomic landscape of renal cell carcinoma: Implications for targeted therapy and precision immuno-oncology

Sanfrancesco, J. M. & Cheng, L., Nov 1 2017, In : Critical Reviews in Oncology/Hematology. 119, p. 23-28 6 p.

Research output: Contribution to journalReview article

11 Scopus citations
2016

Testing PD-1/PD-L1 expression in cancer therapy: Pathologic insights and economic sustainability

Montironi, R., Santoni, M., Tartari, F., Lopez-Beltran, A., Cheng, L., Berardi, R. & Scarpelli, M., Jun 1 2016, In : Archives of Pathology and Laboratory Medicine. 140, 6, p. 501-502 2 p.

Research output: Contribution to journalLetter

8 Scopus citations

FGFR3 and Cyclin D3 as urine biomarkers of bladder cancer recurrence

Blanca, A., Requena, M. J., Alvarez, J., Cheng, L., Montironi, R., Raspollini, M. R., Reymundo, C. & Lopez-Beltran, A., Mar 1 2016, In : Biomarkers in Medicine. 10, 3, p. 243-253 11 p.

Research output: Contribution to journalArticle

10 Scopus citations
2017

Predicting the biological behavior of non-muscle-invasive bladder cancer: From histology to molecular taxonomy

Luchini, C. & Cheng, L., Oct 1 2017, In : Translational Andrology and Urology. 6, 5, p. 987-990 4 p.

Research output: Contribution to journalEditorial

1 Scopus citations
2020

Sequential or Concomitant Inhibition of Cyclin-Dependent Kinase 4/6 Before mTOR Pathway in Hormone-Positive HER2 Negative Breast Cancer: Biological Insights and Clinical Implications

Occhipinti, G., Romagnoli, E., Santoni, M., Cimadamore, A., Sorgentoni, G., Cecati, M., Giulietti, M., Battelli, N., Maccioni, A., Storti, N., Cheng, L., Principato, G., Montironi, R. & Piva, F., Apr 15 2020, In : Frontiers in Genetics. 11, 349.

Research output: Contribution to journalReview article

Open Access
2016

Synchronous clear cell renal cell carcinoma and multilocular cystic renal cell neoplasia of low malignant potential: A clinico-pathologic and molecular study

Raspollini, M. R., Castiglione, F., Cheng, L., Montironi, R. & Lopez-Beltran, A., May 1 2016, In : Pathology Research and Practice. 212, 5, p. 471-474 4 p.

Research output: Contribution to journalArticle

3 Scopus citations
2020

Five decades of urologic pathology: the accelerating expansion of knowledge in renal cell neoplasia

MacLennan, G. T. & Cheng, L., Jan 2020, In : Human pathology. 95, p. 24-45 22 p.

Research output: Contribution to journalArticle

2 Scopus citations
2017

TMPRSS2-ERG gene fusion is rare compared to PTEN deletions in stage T1a prostate cancer

Fisher, K. W., Zhang, S., Wang, M., Montironi, R., Wang, L., Baldrige, L. A., Wang, J. Y., MacLennan, G. T., Williamson, S. R., Lopez-Beltran, A. & Cheng, L., Mar 1 2017, In : Molecular Carcinogenesis. 56, 3, p. 814-820 7 p.

Research output: Contribution to journalArticle

3 Scopus citations

From Gleason Grading System and High-grade Tertiary Patterns to Grade Groups and Integrated Quantitative Gleason Score

Montironi, R., Cheng, L., Scarpelli, M. & Lopez-Beltran, A., 2017, (Accepted/In press) In : European Urology.

Research output: Contribution to journalArticle

2 Scopus citations

Prostate cancer biomarkers: Current status

Hodges, K. B., Bachert, E. & Cheng, L., Jan 1 2017, In : Critical Reviews in Oncogenesis. 22, 5-6, p. 353-369 17 p.

Research output: Contribution to journalReview article

2 Scopus citations
2016

Renal pelvis, ureter, and urethra

Lopez-Beltran, A., Williamson, S. R. & Cheng, L., Feb 13 2016, Essentials of Anatomic Pathology: Fourth Edition. Springer International Publishing, p. 1737-1750 14 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

2019

Expression of miR-100 and miR-138 as prognostic biomarkers in non-muscle-invasive bladder cancer

Blanca, A., Sanchez-Gonzalez, A., Requena, M. J., Carrasco-Valiente, J., Gomez-Gomez, E., Cheng, L., Cimadamore, A., Montironi, R. & Lopez-Beltran, A., Aug 2019, In : APMIS. 127, 8, p. 545-553 9 p.

Research output: Contribution to journalArticle

3 Scopus citations
2016

Prostate cancer glands with cribriform architecture and with glomeruloid features should be considered as Gleason pattern 4 and not pattern 3

Minardi, D., Mazzucchelli, R., Scarpelli, M., Massari, F., Ciccarese, C., Lopez-Beltran, A., Cheng, L. & Montironi, R., Jun 2016, In : Future Oncology. 12, 12, p. 1431-1433 3 p.

Research output: Contribution to journalReview article

4 Scopus citations
2017

A contemporary series of renal masses with emphasis on recently recognized entities and tumors of low malignant potential: A report based on 624 consecutive tumors from a single tertiary center

Raspollini, M. R., Montagnani, I., Montironi, R., Cheng, L., Martignoni, G., Minervini, A., Serni, S., Nicita, G., Carini, M. & Lopez-Beltran, A., Jul 2017, In : Pathology Research and Practice. 213, 7, p. 804-808 5 p.

Research output: Contribution to journalArticle

2 Scopus citations
2019

Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter

Bianconi, M., Cimadamore, A., Faloppi, L., Scartozzi, M., Santoni, M., Lopez-Beltran, A., Cheng, L., Scarpelli, M. & Montironi, R., Jan 1 2019, In : Therapeutic Advances in Urology. 11

Research output: Contribution to journalReview article

4 Scopus citations
2020

Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers

Lopez-Beltran, A., Cheng, L., Gevaert, T., Blanca, A., Cimadamore, A., Santoni, M., Massari, F., Scarpelli, M., Raspollini, M. R. & Montironi, R., Feb 1 2020, In : Expert Review of Molecular Diagnostics. 20, 2, p. 231-243 13 p.

Research output: Contribution to journalReview article

3 Scopus citations
2017

Design and in-vivo evaluation of next-generation laparoscopic HIFU kidney probe

Seip, R., Morris, A., Chaluisan, R., Clanton, J., Carlson, R., Carr, J., Johnson, C., Sanghvi, N., Smith, J., Matam, M., Morris, J., Chopra, S., Gill, I., Shum, C. F., Sundaram, C., Cheng, L. & Carol, M., Oct 31 2017, 2017 IEEE International Ultrasonics Symposium, IUS 2017. IEEE Computer Society, 8092872. (IEEE International Ultrasonics Symposium, IUS).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

2016

Handling of the surgical specimen and pathology reporting of malignant germ cell and sex cord-stromal tumors of the testis

Scarpelli, M., Mazzucchelli, R., Santoni, M., Sotte, V., Conti, A., Lopez-Beltran, A., Cheng, L. & Montironi, R., May 2 2016, Pathology of Testicular and Penile Neoplasms. Springer International Publishing, p. 165-170 6 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

2019

Circulating tumor cells in renal cell carcinoma: Recent findings and future challenges

Santoni, M., Cimadamore, A., Cheng, L., Lopez-Beltran, A., Battelli, N., Massari, F., Scarpelli, M., Galosi, A. B., Bracarda, S. & Montironi, R., 2019, In : Frontiers in Oncology. 9, APR, 228.

Research output: Contribution to journalComment/debate

Open Access
7 Scopus citations

Distinct mutational landscape of inverted urothelial papilloma

Akgul, M., MacLennan, G. T. & Cheng, L., Jan 1 2019, In : Journal of Pathology. 249, 1, p. 3-5 3 p.

Research output: Contribution to journalComment/debate

Open Access
4 Scopus citations

Renal cell carcinoma staging: pitfalls, challenges, and updates

Williamson, S. R., Taneja, K. & Cheng, L., Jan 2019, In : Histopathology. 74, 1, p. 18-30 13 p.

Research output: Contribution to journalReview article

18 Scopus citations
2020

Molecular characteristics of testicular germ cell tumors: pathogenesis and mechanisms of therapy resistance

Al-Obaidy, K. I., Chovanec, M. & Cheng, L., Feb 1 2020, In : Expert Review of Anticancer Therapy. 20, 2, p. 75-79 5 p.

Research output: Contribution to journalEditorial

Open Access

Renal Cell Carcinoma: genomic landscape and clinical implications

Aurilio, G., Santoni, M., Cimadamore, A., Massari, F., Scarpelli, M., Lopez-Beltran, A., Cheng, L., Battelli, N., Nolé, F. & Montironi, R., Mar 3 2020, In : Expert Review of Precision Medicine and Drug Development. 5, 2, p. 95-100 6 p.

Research output: Contribution to journalReview article

2017

Immunotherapy in genitourinary cancers: Where are we going?

Bianconi, M., Faloppi, L., Lopez-Beltran, A., Cheng, L., Cimadamore, A., Gasparrini, S., Massari, F., Scarpelli, M. & Montironi, R., Jan 1 2017, In : Expert Review of Precision Medicine and Drug Development. 2, 2, p. 73-78 6 p.

Research output: Contribution to journalArticle

1 Scopus citations

Activity and Functions of Tumor-associated Macrophages in Prostate Carcinogenesis

Santoni, M., Cheng, L., Conti, A., Mariani, C., Lopez-Beltran, A., Montironi, R. & Battelli, N., Dec 2017, In : European Urology, Supplements. 16, 12, p. 301-308 8 p.

Research output: Contribution to journalReview article

4 Scopus citations
2016

Telomerase reverse transcriptase (TERT) promoter mutation analysis of benign, malignant and reactive urothelial lesions reveals a subpopulation of inverted papilloma with immortalizing genetic change

Cheng, L., Davidson, D. D., Wang, M., Lopez-Beltran, A., Montironi, R., Wang, L., Tan, P. H., MacLennan, G. T., Williamson, S. R. & Zhang, S., Jul 1 2016, In : Histopathology. 69, 1, p. 107-113 7 p.

Research output: Contribution to journalArticle

21 Scopus citations
2017

TMPRSS2-ERG Fusion in an Uncommon Presentation of Prostate Cancer

Adra, N., Cheng, L., Hanna, N. H. & Durm, G., Jun 2017, In : Clinical Genitourinary Cancer. 15, 3, p. e489-e491

Research output: Contribution to journalArticle

2020

The expanding molecular and mutational landscape of nested variant of urothelial carcinoma

Levy, D. R. & Cheng, L., Apr 1 2020, In : Histopathology. 76, 5, p. 638-639 2 p.

Research output: Contribution to journalEditorial

2016

Use of the cell cycle progression (CCP) score for predicting systemic disease and response to radiation of biochemical recurrence

Koch, M., Cho, J. S., Kaimakliotis, H., Cheng, L., Sangale, Z., Brawer, M., Welbourn, W., Reid, J. & Stone, S., 2016, In : Cancer Biomarkers. 17, 1, p. 83-88 6 p.

Research output: Contribution to journalArticle

8 Scopus citations
2017

Epigenetic modifications and modulators in prostate cancer

Cimadamore, A., Gasparrini, S., Scarpelli, M., Doria, A., Mazzucchelli, R., Massari, F., Cheng, L., Lopez-Beltran, A. & Montironi, R., Jan 1 2017, In : Critical Reviews in Oncogenesis. 22, 5-6, p. 439-450 12 p.

Research output: Contribution to journalArticle

2 Scopus citations
2020

The applicability and utility of immunohistochemical biomarkers in bladder pathology

Akgul, M., MacLennan, G. T. & Cheng, L., Apr 2020, In : Human pathology. 98, p. 32-55 24 p.

Research output: Contribution to journalArticle

2 Scopus citations
2016

Human papillomavirus (HPV)-induced neoplasia in the urinary bladder: A missing link?

Alexander, R. E., Wang, L., Lopez-Beltran, A., Emerson, R. E., Montironi, R., Pedrosa, J. A., Kaimakliotis, H. Z., Koch, M. O. & Cheng, L., Jun 2016, In : Histology and Histopathology. 31, 6, p. 595-600 6 p.

Research output: Contribution to journalReview article

6 Scopus citations
2020

PreImplantation Factor immunohistochemical expression correlates with prostate cancer aggressiveness

Raspollini, M. R., Montagnani, I., Cirri, P., Baroni, G., Cimadamore, A., Scarpelli, M., Cheng, L., Lopez-Beltran, A., Montironi, R. & Barnea, E. R., 2020, In : International Journal of Biological Markers. 35, 2, p. 82-90 9 p.

Research output: Contribution to journalArticle

Open Access

New Frontiers in Prostate Cancer Treatment: Are We Ready for Drug Combinations with Novel Agents?

Aurilio, G., Cimadamore, A., Santoni, M., Nolè, F., Scarpelli, M., Massari, F., Lopez-Beltran, A., Cheng, L. & Montironi, R., Jun 22 2020, In : Cells. 9, 6

Research output: Contribution to journalReview article

Open Access
2017

Variants and Variations in Epithelial Renal Cell Tumors in Adults: The Pathologist's Point of View

Montironi, R., Gasparrini, S., Cimadamore, A., Mazzucchelli, R., Massari, F., Cheng, L., Lopez-Beltran, A., Moch, H., Montorsi, F. & Scarpelli, M., Dec 2017, In : European Urology, Supplements. 16, 12, p. 232-240 9 p.

Research output: Contribution to journalReview article

1 Scopus citations

Targeting the programmed cell death-1 pathway in genitourinary tumors: Current progress and future perspectives

Mann, S. A., Lopez-Beltran, A., Massari, F., Pili, R., Fiorentino, M., Koch, M. O., Kaimakliotis, H. Z., Wang, L., Scarpelli, M., Ciccarese, C., Moch, H., Montironi, R. & Cheng, L., Jan 1 2017, In : Current drug metabolism. 18, 8, p. 700-711 12 p.

Research output: Contribution to journalReview article

17 Scopus citations
2016

Emerging immunotargets in bladder cancer

Massari, F., Ciccarese, C., Vau, N., Santoni, M., Montironi, R., Cheng, L., Marques, R. C., Scarpelli, M., Fonseca, J., Matrana, M. R., Holger, M., Cascinu, S., Tortora, G. & Lopez-Beltran, A., Jun 1 2016, In : Current Drug Targets. 17, 7, p. 757-770 14 p.

Research output: Contribution to journalArticle

10 Scopus citations
2017

Urinary biomarkers for prostate cancer

Giunchi, F., Ciccarese, C., Montironi, R., Scarpelli, M., Lopez-Beltran, A., Cheng, L., Moch, H., Massari, F. & Fiorentino, M., Jan 1 2017, In : Current Drug Metabolism. 18, 8, p. 723-726 4 p.

Research output: Contribution to journalReview article

5 Scopus citations
2016

Emerging molecular pathways and targets in neuroendocrine prostate cancer

Monn, M. F., Montironi, R., Lopez-Beltran, A. & Cheng, L., 2016, In : Translational Cancer Research. 5, p. S282-S285

Research output: Contribution to journalComment/debate

2020

pT1 high-grade bladder cancer: histologic criteria, pitfalls in the assessment of invasion, and substaging

Raspollini, M. R., Montironi, R., Mazzucchelli, R., Cimadamore, A., Cheng, L. & Lopez-Beltran, A., Jul 1 2020, In : Virchows Archiv. 477, 1, p. 3-16 14 p.

Research output: Contribution to journalReview article

2019

Editorial: Emerging biomarkers in genitourinary tumors

Montironi, R., Santoni, M., Cimadamore, A., Lopez-Beltran, A. & Cheng, L., 2019, In : Frontiers in Oncology. 9, APR, 326.

Research output: Contribution to journalEditorial

Open Access
2 Scopus citations
2020

Gonadoblastoma: origin and outcome

Roth, L. M. & Cheng, L., Jun 2020, In : Human pathology. 100, p. 47-53 7 p.

Research output: Contribution to journalArticle

2016

Current Histopathologic and Molecular Characterisations of Prostate Cancer: Towards Individualised Prognosis and Therapies

Santoni, M., Scarpelli, M., Mazzucchelli, R., Lopez-Beltran, A., Cheng, L., Epstein, J. I., Cascinu, S., Briganti, A., Catto, J. W., Montorsi, F. & Montironi, R., Feb 1 2016, In : European urology. 69, 2, p. 186-190 5 p.

Research output: Contribution to journalEditorial

8 Scopus citations
2019

Detection of androgen receptor (AR) and AR-V7 in small cell prostate carcinoma: Diagnostic and therapeutic implications

Zhao, P., Zhu, Y., Cheng, L. & Luo, J., Jan 2019, In : Asian Journal of Urology. 6, 1, p. 109-113 5 p.

Research output: Contribution to journalArticle

Open Access
6 Scopus citations
2017
6 Scopus citations
2019

Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysis

Luchini, C., Veronese, N., Nottegar, A., Riva, G., Pilati, C., Mafficini, A., Stubbs, B., Simbolo, M., Mombello, A., Corbo, V., Cheng, L., Yachida, S., Wood, L. D., Lawlor, R. T., Salvia, R. & Scarpa, A., Jan 1 2019, In : Pancreas. 48, 1, p. 70-76 7 p.

Research output: Contribution to journalArticle

2 Scopus citations